title: [Laparoscopic pelvic lymph node dissection for staging procedure in patients with T1-T3 prostate cancer].
abstract: OBJECTIVE
  We evaluated the usefulness and morbidity of laparoscopic pelvic lymph node dissection (LPLND) as a staging procedure for prostate cancer.
  
  
  METHODS
  Twenty-seven patients with T1-T3 prostate cancer scheduled for conformal radiation therapy underwent LPLND.
  
  
  RESULTS
  The median operation time was 103 minutes (range; 58-137 minutes), and the median intraoperative estimated blood loss was 5 ml. (range; very little-273 ml.). This procedure covered obturator nodes and the median number of dissected lymph nodes was 8.0. Median days to oral intake and return to normal activity were 1.0 days and 1.0 days, respectively.
  
  
  CONCLUSIONS
  LPLND appears to be a safe, minimally invasive and useful procedure as a means of accurate staging for patients with prostate cancer undergoing radiation therapy.
authors.affiliation: Department of Urology, Muroran City General Hospital.
authors.forename: Ichiya
authors.initials: I
authors.lastname: Honma
authors.forename: Toshiro
authors.initials: T
authors.lastname: Oda
authors.forename: Takashi
authors.initials: T
authors.lastname: Simizu
authors.forename: Noriomi
authors.initials: N
authors.lastname: Miyao
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Tachiki
authors.forename: Noriaki
authors.initials: N
authors.lastname: Tanaka
mesh_terms: D000368:Aged; D006801:Humans; D010535:Laparoscopy / Q000379:methods*; D008197:Lymph Node Excision / Q000379:methods*; D008297:Male; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures / Q000379:methods; D009367:Neoplasm Staging / Q000379:methods*; D010388:Pelvis; D011471:Prostatic Neoplasms / Q000473:pathology*